Page Industries Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: June 29, 2025, 11:17 am

Competitors of Page Industries Ltd

All Competitor Stocks of Page Industries Ltd

Quarterly Result

Last Updated: May 31, 2025, 8:12 am

Below is a detailed analysis of the quarterly data for Page Industries Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 1,098.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,313.00 Cr. (Dec 2024) to 1,098.00 Cr., marking a decrease of 215.00 Cr..
• For Expenses, as of Mar 2025, the value is 863.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1,011.00 Cr. (Dec 2024) to 863.00 Cr., marking a decrease of 148.00 Cr..
• For Operating Profit, as of Mar 2025, the value is 235.00 Cr.. The value appears to be declining and may need further review. It has decreased from 303.00 Cr. (Dec 2024) to 235.00 Cr., marking a decrease of 68.00 Cr..
• For OPM %, as of Mar 2025, the value is 21.00%. The value appears to be declining and may need further review. It has decreased from 23.00% (Dec 2024) to 21.00%, marking a decrease of 2.00%.
• For Other Income, as of Mar 2025, the value is 20.00 Cr.. The value appears strong and on an upward trend. It has increased from 14.00 Cr. (Dec 2024) to 20.00 Cr., marking an increase of 6.00 Cr..
• For Interest, as of Mar 2025, the value is 12.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 12.00 Cr..
• For Depreciation, as of Mar 2025, the value is 25.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 30.00 Cr. (Dec 2024) to 25.00 Cr., marking a decrease of 5.00 Cr..
• For Profit before tax, as of Mar 2025, the value is 219.00 Cr.. The value appears to be declining and may need further review. It has decreased from 275.00 Cr. (Dec 2024) to 219.00 Cr., marking a decrease of 56.00 Cr..
• For Tax %, as of Mar 2025, the value is 25.00%. The value appears to be improving (decreasing) as expected. It has decreased from 26.00% (Dec 2024) to 25.00%, marking a decrease of 1.00%.
• For Net Profit, as of Mar 2025, the value is 164.00 Cr.. The value appears to be declining and may need further review. It has decreased from 205.00 Cr. (Dec 2024) to 164.00 Cr., marking a decrease of 41.00 Cr..
• For EPS in Rs, as of Mar 2025, the value is 147.04. The value appears to be declining and may need further review. It has decreased from 183.49 (Dec 2024) to 147.04, marking a decrease of 36.45.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 4:33 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: June 16, 2025, 11:35 am

Below is a detailed analysis of the balance sheet data for Page Industries Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 11.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 11.00 Cr..
• For Reserves, as of Mar 2025, the value is 1,396.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,586.00 Cr. (Mar 2024) to 1,396.00 Cr., marking a decrease of 190.00 Cr..
• For Borrowings, as of Mar 2025, the value is 262.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 185.00 Cr. (Mar 2024) to 262.00 Cr., marking an increase of 77.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 974.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 901.00 Cr. (Mar 2024) to 974.00 Cr., marking an increase of 73.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 2,643.00 Cr.. The value appears to be improving (decreasing). It has decreased from 2,683.00 Cr. (Mar 2024) to 2,643.00 Cr., marking a decrease of 40.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 758.00 Cr.. The value appears strong and on an upward trend. It has increased from 488.00 Cr. (Mar 2024) to 758.00 Cr., marking an increase of 270.00 Cr..
• For CWIP, as of Mar 2025, the value is 72.00 Cr.. The value appears to be declining and may need further review. It has decreased from 239.00 Cr. (Mar 2024) to 72.00 Cr., marking a decrease of 167.00 Cr..
• For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Other Assets, as of Mar 2025, the value is 1,813.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,956.00 Cr. (Mar 2024) to 1,813.00 Cr., marking a decrease of 143.00 Cr..
• For Total Assets, as of Mar 2025, the value is 2,643.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,683.00 Cr. (Mar 2024) to 2,643.00 Cr., marking a decrease of 40.00 Cr..

Notably, the Reserves (1,396.00 Cr.) exceed the Borrowings (262.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Page Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 653.71. This value is within the healthy range. It has increased from 510.31 (Mar 24) to 653.71, marking an increase of 143.40.
• For Diluted EPS (Rs.), as of Mar 25, the value is 653.71. This value is within the healthy range. It has increased from 510.31 (Mar 24) to 653.71, marking an increase of 143.40.
• For Cash EPS (Rs.), as of Mar 25, the value is 742.67. This value is within the healthy range. It has increased from 591.73 (Mar 24) to 742.67, marking an increase of 150.94.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 1,261.62. It has decreased from 1,431.71 (Mar 24) to 1,261.62, marking a decrease of 170.09.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 1,261.62. It has decreased from 1,431.71 (Mar 24) to 1,261.62, marking a decrease of 170.09.
• For Dividend / Share (Rs.), as of Mar 25, the value is 900.00. This value exceeds the healthy maximum of 3. It has increased from 370.00 (Mar 24) to 900.00, marking an increase of 530.00.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 4,424.38. It has increased from 4,107.65 (Mar 24) to 4,424.38, marking an increase of 316.73.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 1,007.89. This value is within the healthy range. It has increased from 799.91 (Mar 24) to 1,007.89, marking an increase of 207.98.
• For PBIT / Share (Rs.), as of Mar 25, the value is 918.92. This value is within the healthy range. It has increased from 718.48 (Mar 24) to 918.92, marking an increase of 200.44.
• For PBT / Share (Rs.), as of Mar 25, the value is 877.34. This value is within the healthy range. It has increased from 678.23 (Mar 24) to 877.34, marking an increase of 199.11.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 653.71. This value is within the healthy range. It has increased from 510.30 (Mar 24) to 653.71, marking an increase of 143.41.
• For PBDIT Margin (%), as of Mar 25, the value is 22.78. This value is within the healthy range. It has increased from 19.47 (Mar 24) to 22.78, marking an increase of 3.31.
• For PBIT Margin (%), as of Mar 25, the value is 20.76. This value exceeds the healthy maximum of 20. It has increased from 17.49 (Mar 24) to 20.76, marking an increase of 3.27.
• For PBT Margin (%), as of Mar 25, the value is 19.82. This value is within the healthy range. It has increased from 16.51 (Mar 24) to 19.82, marking an increase of 3.31.
• For Net Profit Margin (%), as of Mar 25, the value is 14.77. This value exceeds the healthy maximum of 10. It has increased from 12.42 (Mar 24) to 14.77, marking an increase of 2.35.
• For Return on Networth / Equity (%), as of Mar 25, the value is 51.81. This value is within the healthy range. It has increased from 35.64 (Mar 24) to 51.81, marking an increase of 16.17.
• For Return on Capital Employeed (%), as of Mar 25, the value is 62.78. This value is within the healthy range. It has increased from 45.94 (Mar 24) to 62.78, marking an increase of 16.84.
• For Return On Assets (%), as of Mar 25, the value is 27.58. This value is within the healthy range. It has increased from 21.21 (Mar 24) to 27.58, marking an increase of 6.37.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.85. It has increased from 1.70 (Mar 24) to 1.85, marking an increase of 0.15.
• For Current Ratio (X), as of Mar 25, the value is 1.72. This value is within the healthy range. It has decreased from 2.00 (Mar 24) to 1.72, marking a decrease of 0.28.
• For Quick Ratio (X), as of Mar 25, the value is 0.87. This value is below the healthy minimum of 1. It has increased from 0.75 (Mar 24) to 0.87, marking an increase of 0.12.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 1.06. This value is below the healthy minimum of 4. It has increased from 0.81 (Mar 24) to 1.06, marking an increase of 0.25.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 60.74 (Mar 24) to 0.00, marking a decrease of 60.74.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 52.38 (Mar 24) to 0.00, marking a decrease of 52.38.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 39.26 (Mar 24) to 0.00, marking a decrease of 39.26.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 47.62 (Mar 24) to 0.00, marking a decrease of 47.62.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 24.24. This value is within the healthy range. It has increased from 19.87 (Mar 24) to 24.24, marking an increase of 4.37.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 16.72. This value is within the healthy range. It has increased from 13.68 (Mar 24) to 16.72, marking an increase of 3.04.
• For Enterprise Value (Cr.), as of Mar 25, the value is 47,229.72. It has increased from 38,079.89 (Mar 24) to 47,229.72, marking an increase of 9,149.83.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 9.57. This value exceeds the healthy maximum of 3. It has increased from 8.31 (Mar 24) to 9.57, marking an increase of 1.26.
• For EV / EBITDA (X), as of Mar 25, the value is 42.01. This value exceeds the healthy maximum of 15. It has decreased from 42.68 (Mar 24) to 42.01, marking a decrease of 0.67.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 9.67. This value exceeds the healthy maximum of 3. It has increased from 8.38 (Mar 24) to 9.67, marking an increase of 1.29.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 39.25 (Mar 24) to 0.00, marking a decrease of 39.25.
• For Price / BV (X), as of Mar 25, the value is 33.90. This value exceeds the healthy maximum of 3. It has increased from 24.05 (Mar 24) to 33.90, marking an increase of 9.85.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 9.67. This value exceeds the healthy maximum of 3. It has increased from 8.38 (Mar 24) to 9.67, marking an increase of 1.29.
• For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness